Literature DB >> 18457050

Role of myeloperoxidase-mediated modification of human blood lipoproteins in atherosclerosis development.

O M Panasenko1, T V Vakhrusheva, I I Vlasova, A V Chekanov, Y V Baranov, V I Sergienko.   

Abstract

The mechanism of interaction of hypochlorite and hypobromite formed in myeloperoxidase catalysis with lipids of human blood low-density lipoprotein is described. Both agents react with unsaturated lipids via two mechanisms: molecular (with the formation of mainly chloro- or bromohydrins and lysophospholipids) and free-radical (paralleled by lipid peroxidation). These reactions modify physicochemical properties of low-density lipoproteins and disorder their lipid-transporting function thus initiating early stages of atherosclerosis development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18457050     DOI: 10.1007/s10517-007-0346-x

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

1.  Macrophages actively accumulate malonyldialdehyde-modified but not enzymatically oxidized low density lipoprotein.

Authors:  V Z Lankin; A K Tikhaze; E M Kumskova
Journal:  Mol Cell Biochem       Date:  2012-02-04       Impact factor: 3.396

2.  Human neutrophils functionality under effect of an Asp49 phospholipase A2 isolated from Bothrops atrox venom.

Authors:  Sulamita da S Setúbal; Adriana S Pontes; Neriane M Nery; Cristina M A Rego; Hallison M Santana; Anderson M de Lima; Charles N Boeno; Mauro V Paloschi; Andreimar M Soares; Juliana P Zuliani
Journal:  Toxicon X       Date:  2020-03-18

Review 3.  The role of lipid peroxidation in neurological disorders.

Authors:  Mototada Shichiri
Journal:  J Clin Biochem Nutr       Date:  2014-04-09       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.